Accelerate the Journey from Preclinical to Phase 1
Gain actionable strategies to optimise candidate selection and dosage form design so your programme is positioned for regulatory success and stronger investment valuation.

From Preclinical Promise to Phase 1 Valuation
In partnership with

Event Overview
From Preclinical Promise to Phase 1 Valuation
Event Details
Date
27th November 2026
Venue
Seda
Lakehouse, Lakeside, Cheadle Royal Business Park, Cheadle SK8 3AX
Format
1-Day Executive Summit + Facility Tour
Biotech Targeting provides optional logistical support for confirmed delegates, including the coordination of travel and accommodations, to facilitate seamless attendance.
To ensure a high-level technical dialogue, attendance at this summit is strictly limited to 10-15 senior industry leaders.
Event Overview
Integrating predictive science, CMC, and commercial strategy to de-risk development and accelerate FIH readiness.
Navigating the journey from molecule to medicine comes with notable hurdles and pitfalls, many of them occurring before candidate drugs are even tested in humans for the first time.
This event explores the key success factors for progressing candidate drugs into Phase 1 clinical studies and discusses how to build the commercial story, choose the right molecules, and design the most suitable dosage forms.
Experts in market access, commercialisation, DMPK, clinical pharmacology, non-clinical safety assessment, and CMC will share their views on the best routes to development success while attendees tour Seda’s PDS and CMS campuses.
What's Included
This summit is strictly limited to an intimate cohort of 10–15 senior industry leaders. To ensure a seamless journey to Cheadle, Biotech Targeting provides optional logistical coordination for all event attendees:
We offer door-to-door travel support for qualified delegates, coordinating train travel and local executive transfers from nearby stations directly to the Seda campus.
Optional assistance in securing local hotel accommodations is available to ensure your trip is simple and efficient.
Access to high-value leadership conversations and structured networking sessions throughout the day with industry peers.
Complete access to all expert sessions, the facility tours of the Seda PDS and CMS campuses, and the closing Q&A forum with Seda scientific and manufacturing leadership.
Key Benefits of Attending
Designed specifically for senior decision-makers navigating the critical path from preclinical promise to first-in-human valuation.
Gain actionable strategies to optimise candidate selection and dosage form design so your programme is positioned for regulatory success and stronger investment valuation.
Learn how to leverage in-silico modelling and biopharmaceutics to predict human dose and performance early, removing technical hurdles before they reach the clinic.
Get practical guidance on the bridge between non-clinical safety assessments and pharmaceutical development so your CMC strategy fully supports FIH readiness.
Tour Seda’s PDS and CMS campuses and engage in a rapid-fire Q&A with the leadership team to solve formulation and tech transfer bottlenecks.
Explore API-sparing approaches to formulation that help teams develop robust clinical products rapidly and transition them cleanly into GMP manufacturing.
Connect with a curated cohort of leaders across CMC, clinical pharmacology, DMPK, and regulatory affairs during peer-to-peer sessions.
Who Should Attend
Specifically designed for senior leaders navigating the transition from lead optimisation and preclinical development through to first-in-human readiness.
Including titles such as:
Chief Scientific Officer (CSO) / Chief Technology Officer (CTO)
VP / SVP of Drug Development, CMC, or Clinical Pharmacology
Head of Preclinical Development or DMPK
Director of Pharmaceutical Development, Formulation, or Product Design
Senior Director of Regulatory Affairs, Quality, and Program Management
Agenda
A focused, one-day summit combining expert-led case studies, predictive modelling workshops, facility tours, and peer-to-peer roundtables. Registration includes optional, complimentary access to private VIP strategy dinners hosted the evening before and the night of the event.
Built for the drug development and biotech community, by the pioneers shaping it. Learn how to accelerate your molecules from bench to bedside from the teams driving real-world clinical success.
Seda Pharmaceutical Development Services is a UK-based CRDMO focused on model-informed development of medicinal products by integrating DMPK sciences, clinical pharmacology, formulation development, and GMP manufacturing. Its integrated approach helps teams define the right dose, the right formulation, and the right release profile from lead optimisation through first-in-human readiness. Seda’s in silico modelling and API-sparing formulation capabilities are designed to accelerate development of complex molecules, including low-solubility compounds, permeation-challenged assets, and short half-life products, while supporting a clean transfer into GMP manufacturing.
FingerPost Consulting supports BioTech and Pharmaceutical leaders by aligning commercial realities with scientific innovation through market access, pricing strategies, and commercial insights for early asset development. FingerPost facilitates informed investment decisions, navigation of complex acquisitions, and the development of successful exit strategies to ensure long-term commercial viability.
An Exclusive, Executive-Level Gathering
To deliver a high-impact, actionable deep-dive into the translational gap, attendance is strictly limited to 15–20 senior scientific and development leaders.
This invitation-only summit is designed to provide rare, behind-the-scenes access to Seda PDS and CMS campuses and facilitate high-level strategy sessions with your peers.
Registration is entirely complimentary and includes round-trip travel support, premium accommodations, and private dining access for qualified delegates.
Secure your place today to join your peers and accelerate the path from preclinical promise to Phase 1 valuation.
Register Now
Attendance is limited to 15-20 senior leaders.
Registration is fully complimentary, including travel support, premium accommodations, and private dining.
Discuss your objectives with our senior consultants or get the prospectus for our next invitation-only meetings.
Connecting innovators in pharma and biotech through bespoke B2B engagement formats.
Address:
Bmlg.02 10 Barley Mow Passage,
London, United Kingdom, W4 WPH